Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Muscarinic acetylcholine receptor M3 | ||
Ligand | BDBM50522813 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1888526 (CHEMBL4390203) | ||
Ki | 2.6±n/a nM | ||
Citation | Yamashita, Y; Tanaka, KI; Yamakawa, N; Asano, T; Kanda, Y; Takafuji, A; Kawahara, M; Takenaga, M; Fukunishi, Y; Mizushima, T Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity. Bioorg Med Chem27:3339-3346 (2019) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Muscarinic acetylcholine receptor M3 | |||
Name: | Muscarinic acetylcholine receptor M3 | ||
Synonyms: | ACM3_HUMAN | CHRM3 | Cholinergic, muscarinic M3 | Muscarinic Receptors M3 | Muscarinic receptor M3 | RecName: Full=Muscarinic acetylcholine receptor M3 | ||
Type: | Enzyme | ||
Mol. Mass.: | 66151.03 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P20309 | ||
Residue: | 590 | ||
Sequence: |
| ||
BDBM50522813 | |||
n/a | |||
Name | BDBM50522813 | ||
Synonyms: | CHEMBL4539799 | ||
Type | Small organic molecule | ||
Emp. Form. | C30H33Br2NO3 | ||
Mol. Mass. | 615.396 | ||
SMILES | [Br-].OC(C(=O)OC1C[N+]2(CCCc3ccc(Br)cc3)CCC1CC2)(c1ccccc1)c1ccccc1 |(60.03,-19.13,;50.39,-21.97,;51.73,-22.75,;53.06,-23.51,;53.07,-25.05,;54.39,-22.74,;55.73,-23.51,;57.06,-22.73,;58.38,-23.51,;59.72,-22.74,;61.05,-23.51,;62.38,-22.74,;63.72,-23.52,;63.71,-25.05,;65.04,-25.83,;66.38,-25.06,;67.71,-25.83,;66.37,-23.51,;65.04,-22.75,;58.39,-25.05,;57.06,-25.81,;55.73,-25.05,;57.22,-24.84,;56.87,-23.79,;51.72,-21.21,;53.05,-20.44,;53.05,-18.9,;51.71,-18.13,;50.38,-18.91,;50.39,-20.45,;50.39,-23.52,;49.06,-22.75,;47.73,-23.52,;47.73,-25.06,;49.08,-25.83,;50.4,-25.05,)| | ||
Structure |